| [1] |
Dusse LM, Alpoim PN, Silva JT, et al. Revisiting HELLP syndrome [J]. Clin Chim Acta, 2015, 451(Pt B): 117-120.
|
| [2] |
Kirkpatrick CA. The HELLP syndrome [J]. Acta Clin Belg, 2010, 65(2): 91-97.
|
| [3] |
Cindrova-Davies T. Gabor Than Award Lecture 2008: pre-eclampsia-from placental oxidative stress to maternal endothelial dysfunction [J]. Placenta, 2009, 30 Suppl A: S55-S65.
|
| [4] |
Simsek Y, Gul M, Celik O, et al. Nuclear transcription factor-kappa beta-dependent ultrastructural alterations within the placenta and systemic inflammatory activation in pregnant patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome: a case-control study [J]. Hypertens Pregnancy, 2013, 32(3): 281-291.
|
| [5] |
Stojanovska V, Zenclussen AC. Innate and Adaptive Immune Responses in HELLP Syndrome [J]. Front Immunol, 2020, 11: 1-10.
|
| [6] |
Sandvoß M, Potthast AB, von Versen-Höynck F, et al. HELLP Syndrome [J]. Reprod Sci, 2017, 24(4): 568-574.
|
| [7] |
Haram K, Mortensen JH, Nagy B. Genetic aspects of preeclampsia and the HELLP syndrome [J]. J Pregnancy, 2014, 2014: 1-13.
|
| [8] |
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222 [J]. Obstet Gynecol, 2020, 135(6): e237-e260.
|
| [9] |
Rimaitis K, Grauslyte L, Zavackiene A, et al. Diagnosis of HELLP Syndrome: A 10-Year Survey in a Perinatology Centre [J]. Int J Environ Res Public Health, 2019, 16(1): 109.
|
| [10] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020) [J]. 中华妇产科杂志，2020, 50(10): 721-728.
|
| [11] |
Jiang R, Wang T, Li B, et al. Clinical characteristics and pregnancy outcomes of atypical hemolysis, elevated liver enzymes, and low platelets syndrome: A case series [J]. Medicine (Baltimore), 2020, 99(18): 1-4.
|
| [12] |
Rojas-Arias JL, Ortiz-López LD, Orduña-Aparicio WJ, et al. Characterization of Atypical Preeclampsia [J]. Fetal diagnosis and therapy, 2015, 38(2): 119-125.
|
| [13] |
Graupner O, Karge A, Flechsenhar S, et al. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia [J]. Arch Gynecol Obstet, 2020, 301(2): 375-385.
|
| [14] |
Stiefel P, Miranda ML, Macher H, et al. Description of a strong relationship among total cell-free DNA levels, LDH values, AST values and platelet count in patients with HELLP syndrome [J]. Hypertens Res, 2017, 40(9): 843-845.
|
| [15] |
Schnabel A, Blois SM, Meint P, et al. Elevated systemic galectin-1 levels characterize HELLP syndrome [J]. J Reprod Immunol, 2016, 114: 38-43.
|
| [16] |
De Villiers CP, Hedley PL, Placing S, et al. Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia [J]. Clin Chem Lab Med, 2017, 56(1): 65-74.
|
| [17] |
Yoshida Y, Matsumoto M, Yagi H, et al. Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome [J]. Blood Adv, 2017, 1(20): 1628-1631.
|
| [18] |
Maged AM, ElNassery N, Fouad M, et al. Third-trimester uterine artery Doppler measurement and maternal postpartum outcome among patients with severe pre-eclampsia [J]. Int J Gynaecol Obstet, 2015, 131(1): 49-53.
|
| [19] |
Cetin O, Karaman E, Arslan H, et al. Evaluation of maternal liver elasticity by acoustic radiation force impulse elastosonography in hypertensive disorders of pregnancy: a preliminary descriptive study [J]. J Matern Fetal Neonatal Med, 2017, 30(19): 2281-2286.
|
| [20] |
El Allani L, Benlamkaddem S, Berdai MA, et al. A case of massive hepatic infarction in severe preeclampsia as part of the HELLP syndrome [J]. Pan Afr Med J, 2020, 36: 1-6.
|
| [21] |
Wallace K, Harris S, Addison A, et al. HELLP Syndrome: Pathophysiology and Current Therapies [J]. Curr Pharm Biotechnol, 2018, 19(10): 816-826.
|
| [22] |
Woudstra DM, Chandra S, Hofmeyr GJ, et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy [J]. Cochrane Database Syst Rev, 2010, (9): 1-73.
|
| [23] |
Takahashi A, Kita N, Tanaka Y, et al. Effects of high-dose dexamethasone in postpartum women with class 1 haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome [J]. J Obstet Gynaecol, 2019, 39(3): 335-339.
|
| [24] |
Cavaignac-Vitalis M, Vidal F, Simon-Toulza C, et al. Conservative versus active management in HELLP syndrome: results from a cohort study [J]. J Matern Fetal Neona, 2019, 32(11): 1769-1775.
|
| [25] |
Cadoret F, Guerby P, Cavaignac-Vitalis M, et al. Expectant management in HELLP syndrome: predictive factors of disease evolution [J]. J Matern Fetal Neona, 2020: 1-6.
|
| [26] |
Fardelmann KL, Alian AA. Anesthesia for Obstetric Disasters [J]. Anesthesiol Clin, 2020, 38(1): 85-105.
|
| [27] |
Simetka O, Klat J, Gumulec J, et al. Early identification of women with HELLP syndrome who need plasma exchange after delivery [J]. Transfus Apher Sci, 2015, 52(1): 54-59.
|
| [28] |
Hogg JP 3rd, Szczepanski JL, Collier C, et al. Immediate postpartum management of patients with severe hypertensive disorders of pregnancy: pathophysiology guiding practice [J]. J Matern Fetal Neona, 2020: 1-11.
|